Zhao Wen-Jing, Huang Mo-Ran, Shang Zhan-Peng, Wang Zi-Jian, Wang Zhi-Bin, Zhang Jia-Yu
School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China.
Beijing Institution of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
Zhongguo Zhong Yao Za Zhi. 2018 Jan;43(1):174-182. doi: 10.19540/j.cnki.cjcmm.2018.0005.
An efficient method of ultra-high performance liquid chromatography coupled with linear ion trap-Orbitrap (UHPLC-LTQ-Orbitrap) mass spectrometer was established to elucidate the metabolites of tanshinone Ⅰ and tanshinone ⅡA in rats. Urine and plasma samples were collected after oral gavage. After processing biological sample by solid phase extraction, Waters ACQUITY HPLC BEH C₁₈ column (2.1 mm×100 mm, 1.7 μm) was used with 0.1% formic acid (A) - acetonitrile (B) solution as the mobile phase for gradient elution. The plasma, urine and the blank samples were then analyzed by ESI-LTQ-Orbitrap equipped with an ESI ion source under positive ion mode. On the basis of the accurate mass measurements, multiple mass spectra and comparison of data with published literature, a total of 26 metabolites were tentatively identified and characterized in the rat samples. Among them, 7 metabolites were derived from tanshinone Ⅰ through metabolic pathways of glucuronide conjugation, hydroxylation, reduction reaction, demethylation reaction, methylation, sulfate conjugation and their composite reactions. Nineteen metabolites were derived from tanshinone ⅡA through metabolic pathways of hydroxylation, reduction reaction, methylation, sulfate conjugation, glucuronidation, glucosylation and their complicated reactions. The results showed that the metabolism of tanshinone Ⅰ and tanshinone ⅡA in rats could be comprehensively clarified by using UHPLC-LTQ-Orbitrap mass spectrometer, providing material basis for the further research in terms of pharmacodynamics, toxicology, and secondary development of Chinese medicine.
建立了一种超高效液相色谱-线性离子阱-轨道阱(UHPLC-LTQ-Orbitrap)质谱联用的高效方法,以阐明丹参酮Ⅰ和丹参酮ⅡA在大鼠体内的代谢产物。灌胃给药后收集尿液和血浆样本。通过固相萃取处理生物样品后,使用Waters ACQUITY HPLC BEH C₁₈柱(2.1 mm×100 mm,1.7 μm),以0.1%甲酸(A)-乙腈(B)溶液为流动相进行梯度洗脱。然后,采用配备电喷雾离子源的ESI-LTQ-Orbitrap在正离子模式下对血浆、尿液及空白样品进行分析。基于精确质量测量、多级质谱以及与已发表文献的数据比较,在大鼠样品中初步鉴定并表征了总共26种代谢产物。其中,7种代谢产物是丹参酮Ⅰ通过葡萄糖醛酸结合、羟基化、还原反应、去甲基化反应、甲基化、硫酸结合及其复合反应等代谢途径产生的。19种代谢产物是丹参酮ⅡA通过羟基化、还原反应、甲基化、硫酸结合、葡萄糖醛酸化、糖基化及其复杂反应等代谢途径产生的。结果表明,利用UHPLC-LTQ-Orbitrap质谱仪可全面阐明丹参酮Ⅰ和丹参酮ⅡA在大鼠体内的代谢情况,为中药的药效学、毒理学及二次开发等进一步研究提供物质基础。